Davie, FL, United States of America

Mongkol Sriwongjanya

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 2000-2012

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Mongkol Sriwongjanya: Innovator in Pharmaceutical Formulations

Introduction

Mongkol Sriwongjanya is a notable inventor based in Davie, Florida, recognized for his contributions to pharmaceutical formulations. He holds a total of five patents, showcasing his innovative approach to drug development and delivery systems.

Latest Patents

Among his latest patents is an antihistamine and decongestant system. This invention relates to an oral pharmaceutical formulation that employs a compressed core containing a decongestant or its pharmaceutically acceptable salt, a delayed release coating on the compressed core, and immediate release therapeutic amounts of both a decongestant and an antihistamine. Another significant patent is for a formulation and process for drug-loaded cores. This invention focuses on a controlled release pellet of metoprolol and its pharmaceutically acceptable salts, utilizing a water-soluble or water-swellable inert starting seed or core.

Career Highlights

Mongkol has worked with prominent companies in the pharmaceutical industry, including Andrx Pharmaceuticals, Inc. and Andex Pharmaceuticals, Inc. His work in these organizations has contributed to advancements in drug formulation and delivery.

Collaborations

Throughout his career, Mongkol has collaborated with talented individuals such as Timothy Weng and Samuel Yuk. These partnerships have fostered innovation and development in his projects.

Conclusion

Mongkol Sriwongjanya's work in pharmaceutical formulations has led to significant advancements in the field. His innovative patents and collaborations highlight his commitment to improving drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…